Literature DB >> 16288528

Dragmacidin E synthesis studies. Preparation of a model cycloheptannelated indole fragment.

Ken S Feldman1, Paiboon Ngernmeesri.   

Abstract

[reaction: see text] The conversion of N-2,2-dichloropropionyl indole methyl ester into a tetracyclic cycloheptannelated indole model compound for the synthesis of dragmacidin E was accomplished in 10 steps. Key reactions include a Witkop cyclization to fashion a C-C bond at C(4) of the indole nucleus and a subsequent Dieckmann cyclization to deliver the desired cycloheptanoid ring.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16288528     DOI: 10.1021/ol0522081

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  6 in total

1.  Total synthesis of (±)-dragmacidin E.

Authors:  Ken S Feldman; Paiboon Ngernmeesri
Journal:  Org Lett       Date:  2011-09-29       Impact factor: 6.005

2.  A strategy for the total synthesis of dragmacidin E. Construction of the core ring system.

Authors:  Raymond J Huntley; Raymond L Funk
Journal:  Org Lett       Date:  2006-10-12       Impact factor: 6.005

3.  Syntheses of Cyclic Guanidine-Containing Natural Products.

Authors:  Yuyong Ma; Saptarshi De; Chuo Chen
Journal:  Tetrahedron       Date:  2015-02-25       Impact factor: 2.457

4.  Total Synthesis of (±)-Dragmacidin E: Problems Solved and Lessons Learned.

Authors:  Ken S Feldman; Paiboon Ngernmeesri
Journal:  Synlett       Date:  2012-08       Impact factor: 2.454

5.  Dragmacidin E synthesis studies. Preparation of a model heptacyclic core structure.

Authors:  Ken S Feldman; Paiboon Ngernmeesri
Journal:  Org Lett       Date:  2010-10-15       Impact factor: 6.005

Review 6.  Recent Advances in Rapid Synthesis of Non-proteinogenic Amino Acids from Proteinogenic Amino Acids Derivatives via Direct Photo-Mediated C-H Functionalization.

Authors:  Zhenbo Yuan; Xuanzhong Liu; Changmei Liu; Yan Zhang; Yijian Rao
Journal:  Molecules       Date:  2020-11-12       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.